Photo Credit: AsiaVision

The following is a summary of “Evolution of the Quality of Life of Long-Term Fibromyalgia Users of Millimeter Wave-Based Neuromodulation: A Real-World Retrospective Study,” published in the March 2025 issue of Journal of Pain Research by Minier et al. 

Fibromyalgia (FM), a condition characterized by widespread pain and various associated symptoms, significantly diminished patients’ QoL and presented a substantial medical challenge.  

Researchers conducted a retrospective study to report real-world data on the 18-month use of a millimeter (MMW)-based neuromodulation device and tracking application, examining its effects on various health dimensions in individuals with self-declared FM.  

They analyzed data on daily MMW wristband use and health parameters, assessed at baseline (D0), and tracked weekly (pain, stiffness, fatigue) or quarterly (QoL, quality of sleep, impression of change). Eligibility required a self-reported FM diagnosis and consistent device use for at least 18 months. Among 185 users meeting the criteria, Fibromyalgia Impact Questionnaire (FIQ) scores dropped by 27% within 3 months (M3), reflecting improved QoL, followed by stabilization. Sleep quality, stiffness, and fatigue also improved, while pain intensity steadily declined over the 18-month period.  

The results showed that 185 users met the inclusion criteria.The FIQ scores decreased by 27% within M3, reflecting improved QoL and later stabilization. Sleep quality, stiffness, and fatigue also showed improvement. Pain intensity consistently declined throughout the 18-month period.  

Investigators concluded the MMW device’s sustained relief of pain, improved sleep quality, and enhanced QoL exhibited its long-term effectiveness for individuals with FM. 

Source: dovepress.com/evolution-of-the-quality-of-life-of-long-term-fibromyalgia-users-of-mi-peer-reviewed-fulltext-article-JPR